Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection

AIDS

Volumn 11, Issue 13, 1997, Pages 1565-1574

  Dyer, Wayne B ^a,c   Geczy, Andrew F ^a   Kent, Stephen J ^b   McIntyre, Larissa B ^a   Blasdall, Sean A ^a   Learmont, Jennifer C ^a   Sullivan, John S ^a  

^a New South Wales Red Cross Blood Bank   (Australia)

^b Epidemiol and Social Research Unit   (Australia)

^c NSW Red Cross   (Australia)

Author keywords

Asymptomatic; Cellular immunity; Disease progression; HIV 1; Live attenuated vaccine; Long term non progressor; Lymphoproliferation; nef; Transfusion

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE; NEF PROTEIN;

ADULT; AGED; ARTICLE; BLOOD BANK; BLOOD TRANSFUSION; CELLULAR IMMUNITY; CONTROLLED STUDY; DELETION MUTANT; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SEXUALLY TRANSMITTED DISEASE; VIRUS ATTENUATION; VIRUS TRANSMISSION;

ADULT; AGED; AUSTRALIA; BLOOD BANKS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; COHORT STUDIES; FEMALE; GENE PRODUCTS, NEF; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; SEQUENCE DELETION; SURVIVORS;

EID: 0030785330     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199713000-00004     Document Type: Article

References (31)

1. Pantaleo G, Graziosi C, Lauci AS: The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993, 328:327 335.
2. Lifson AR, Rutherford GW, Jafte JW: The natural history of human immunodeficiency virus infection. J Infect Dis 1988, 158:1360 1367.
3. Jason J. Lui K-J, Ragni MV, Hessol NA, Darrow WW: Risk of developing AIDS in HIV-infected cohorts of haemophiliac and homosexual men. JAMA 1989, 261:725 727.
4. Learmont J. Lindall B, Evans L, et al.: Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992, 340:863 867.
5. Schrager LK, Young JM, Lower MG, Mathieson BJ, Vermund SH: Long-term survivors of HIV-1 infection: definitions and research challenges. AIDS 1994, 8 (Suppl 1):S95 S108.
6. Buchbinder SP, Katz MH, Hessol NA O'Malley PM, Holmberg SD: Long-term HIV-1 infection without immunologic progression. AIDS 1994, 8:1123 1128.
7. Deacon NJ, Isykin A, Solomon A, et al.: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995, 270:988 991.
8. Levacherr M, Fallet S, Dazza MC, et al.: T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS. Clin Exp Immunol 1990, 81:177 182.
9. Moss AR, Bacchetti P, Osmond D, et al.: Seropositivity for HIV and the development of AIDS or AIDS-related condition: three year follow up of the San Francisco General Hospital cohort. BMJ 1988, 296:745 750.
10. Clerici M, Stocks NI, Zajac RA, et al.: Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 1989, 339:383 385.
11. Clerici M, Stocks NI, Zajac RA, et al.: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J Clin Invest 1989, 84:1892 1899.
12. Pontesilli O, Carlesimo M, Varani AR, et al.: HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individuals. Clin Exp Immunol 1995, 100:419-424.
13. Hickie C, Hickie I, Silove D, WAkefield D, Lloyd A: Delayed-type hypersensitivity skin testing: normal values in the Australian population. Int J Immunopharmacol 1994, 17:629 634
14. Sears S, Fox R, Brookmeyer R, Feavitt R, Polk B: Delayed hypersensitivity skin testing and anergy in a population of gay men. Clin Immunol Immunopathol 1987, 45:177 183.
15. Markowitz N, Hansen N, Wilcosky C, et al.: Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med 1993, 119:185 193.
16. Krowka II, Stites DP, Jain S, et al.: Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J Clin Invest 1989, 83:1198 1203.
17. Wahren B, Morteldt-Mansson I, Biberteld G, et al.: Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol 1987, 61:2017 2023.
18. Schrier RD, Wiley CA, Spina C, McCutchan JA, Grant I, HNRC Group: Pathogenic and protective correlates of T cell proliferation in AIDS. J Clin Invest 1996, 98:731 740.
19. Mutch D, Underwood J, Geysen M, Rodda S: Comprehensive T-cell epitope mapping of HIV-1 env antigens reveals many areas recognised by HIV-1-seropositive and by low-risk HIV-1-seronegative individuals. J Acquir Immune Detic Syndr 1994, 7:879 890.
20. Westby M, Manca I, Dalgleish AG: The role of host immune responses in determining the outcome of HIV infection. Immunol Lodav 1996, 17:120 126.
21. Chou C-C, Guideman V, O'Rourke S, et al.: Phenotypically defined memory CD4+cells are not selectively decreased in chronic HIV disease. J Acquir Immune Detic Syndr 1994, 7:665 675.
22. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996, 383:787 793.
23. Greenway A, Azad A, McPhee D: Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J Virol 1995, 69:1842 1850.
24. Luria S, Chambers I, Berg P: Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci U S A 1991, 88:5326 5330.
25. Michael NL, Chang G, d'Arcy LA, et al.: Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J Virol 1995, 69:4228 4236.
26. Liegler IJ, Stites DP: HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. J Acquir Immune Detic Syndr 1994, 7:340 348.
27. Sheppard HW, Lang W, Ascher MS, Vittinghoff I, Winkelstein W: The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS 1993, 7:1159 1166.
28. Greenough JC, Somasundaran M, Brettler DB, et al.: Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1994, 10:395 403.
29. Dolan MJ. Clerici M, Blatt SP, et al.: In vitro T cell function, delayed-type hypersensitivity skin testing and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 1993, 173:79 87.
30. Miller RA: The aging immune system: primer and prospectus. Science 1996, 273:70 74.
31. Wikby A, Johansson B, Ferguson I, Olsson J: Age-related changes in immune parameters in a very old population of Swedish people: a logitudinal study. Exp Gerontol 1994, 29:531 541.